Morgan Stanley analyst Bob Huang raised the firm’s price target on Lemonade to $14 from $13 and keeps an Underweight rating on the shares. While the company saw stronger than expected underwriting improvements and gave a stronger than expected outlook for 2024, the company’s path to profitability “remains somewhat long” and execution risk remains, the analyst tells investors. The firm sees better risk/reward elsewhere given the stock’s recent run up, the analyst added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LMND:
- LMND Earnings: Lemonade Drops As Q1 Forecast Disappoints
- Lemonade Inc. Releases Q4 Supplementary Shareholder Information
- Lemonade Inc (LMND) Q4 Earnings Cheat Sheet
- Short Report: Bears boost WW exposure ahead of earnings after marketing debacle
- Lemonade call volume above normal and directionally bullish